Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:cyclooxygenase 3 inhibitor
go back to main search page
Accession:CHEBI:73263 term browser browse the term
Definition:A cyclooxygenase inhibitor that interferes with the action of cyclooxygenase 3.
Synonyms:related_synonym: COX-3 inhibitor;   COX-3 inhibitors;   cyclo-oxygenase 3 inhibitor;   cyclo-oxygenase 3 inhibitors;   cyclooxygenase-3 inhibitors
 xref: PMID:12242329;   PMID:12374850;   PMID:14592546;   Wikipedia:COX-3


show annotations for term's descendants           Sort by:
 





Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19792
    role 19738
      biological role 19737
        biochemical role 19241
          enzyme inhibitor 18163
            EC 1.* (oxidoreductase) inhibitor 16526
              EC 1.14.* (oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor 14225
                EC 1.14.99.* (miscellaneous oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor 12523
                  EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor 12523
                    cyclooxygenase 3 inhibitor 10693
                      antipyrine + 3
                      metamizole 0
                      metamizole sodium 7
                      paracetamol + 10691
                      phenacetin 78
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.